comparemela.com

Latest Breaking News On - தலைமை அரசு உறவுகள் அதிகாரி - Page 1 : comparemela.com

Chefs Warehouse Inc (CHEF) Q2 2021 Earnings Call Transcript

Greetings, and welcome to the Chefs Warehouse Second Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to turn this conference over to your host, Alex Aldous, General Counsel, Corporate Secretary and Chief Government Relations Officer. Please go ahead, sir. You may begin. Alexandros Aldous General Counsel, Chief Government Relations Officer and Corporate Secretary Thank you, operator. Good morning, everyone. With me on today s call are Chris Pappas, Founder, Chairman and CEO and Jim Leddy, our CFO. By now, you should have access to our second quarter 2021 earnings press release. It can also be found at www.chefswarehouse.com under the Investor Relations section. Throughout this conference call, we will be presenting non-GAAP financial measures, including among others, historical and estimated EBITDA and adjusted EBITDA as well as both historical and estimated adjusted net income and adjusted earnings per share. These measurements are not calculat

Invest in Connecticut s continuum of community-based care before it s too late

Invest in Connecticut’s continuum of community-based care before it’s too late For patients who struggle with severe mental illness, behavioral home health can serve as one of the few – if not only – tethers between them and the community in which they live. As part of a broader set of services known as skilled home health care, behavioral home health allows these patients to receive physical and mental health care, as well as medication administration and oversight, from the comfort of their own homes, rather than in large institutional settings such as a skilled nursing facility, residential psychiatric hospital, or correctional institution.

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax s SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic. Centi-B9 has been engineered to broadly neutralize the mutated emerging coronavirus variants, with demonstrated broad-spectrum reactivity against 99.5% of all coronavirus variants in the U.S.A, and over 98% of coronavirus variants globally, including critical mutations found in the UK B.1.1.7, South African B.1.351, Brazilian P.1, New York B.1.526 and California B.1.429 strains.

Centivax and U S Naval Medical Research Center Announce Strategic Partnership to Initiate Clinical Development of a Broad-Spectrum Injectable For COVID-19, With $4 2M From the Henry Jackson Foundation

Centivax and U S Naval Medical Research Center Announce Strategic Partnership to Initiate Clinical Development of a Broad-Spectrum Injectable For COVID-19, With $4 2M From the Henry Jackson Foundatio

Centivax and U S Naval Medical Research Center Announce Strategic Partnership to Initiate Clinical Development of a Broad-Spectrum Injectable For COVID-19, With $4 2M From the Henry Jackson Foundatio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.